Cadila Healthcare up 1% on USFDA final approval for Allopurinol tablets News News / News 7 years ago 558 Views comments Zydus Cadila has received final approval from the USFDA to market Allopurinol Tablets USP, 100 mg and 300 mg. Read more
News Dixon Technologiesâ IPO to open tomorrow. What are brokerages talking about it? News / News - 7 years ago
Comments